BFA
PTLA

BlackRock Fund Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BlackRock Fund Advisors’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$51.8M Buy
2,309,648
+251,317
+12% +$4.91M 0.01% 1664
2016
Q3 		$46.7M Buy
2,058,331
+109,789
+6% +$2.58M 0.01% 1625
2016
Q2 		$46M Sell
1,948,542
-36,578
-2% -$903K 0.01% 1554
2016
Q1 		$40.5M Buy
1,985,120
+82,609
+4% +$2.62M 0.01% 1578
2015
Q4 		$97.9M Buy
1,902,511
+130
+0% +$6.3K 0.02% 981
2015
Q3 		$81.1M Buy
1,902,381
+104,668
+6% +$5.05M 0.02% 1061
2015
Q2 		$81.9M Sell
1,797,713
-2,901
-0.2% -$117K 0.02% 1159
2015
Q1 		$68.4M Buy
1,800,614
+125,966
+8% +$4.33M 0.02% 1288
2014
Q4 		$47.4M Buy
1,674,648
+376,728
+29% +$10.5M 0.01% 1498
2014
Q3 		$32.8M Sell
1,297,920
-1,403
-0.1% -$37K 0.01% 1638
2014
Q2 		$37.9M Buy
1,299,323
+543,086
+72% +$13.1M 0.01% 1589
2014
Q1 		$19.6M Buy
756,237
+32,278
+4% +$861K 0.01% 2007
2013
Q4 		$18.6M Buy
723,959
+474,878
+191% +$11.5M 0.01% 2028
2013
Q3 		$6.66M Buy
249,081
+29,713
+14% +$707K ﹤0.01% 2602
2013
Q2 		$5.39M Buy
+219,368
New +$4.36M ﹤0.01% 2640

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Fund Advisors's PTLA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 12% in Q4 2016, buying an estimated $4.91M and bringing the position to 2,309,648 shares worth $51.8M. The position accounts for 0.01% of the portfolio, ranked #1664.

BlackRock Fund Advisors first reported a position in PTLA in Q2 2013 and has held it in 15 quarters since. The position peaked at $97.9M in Q4 2015. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

  • BlackRock Fund Advisors held 2,309,648 shares of Portola Pharmaceuticals, Inc. worth $51.8M as of Q4 2016.
  • BlackRock Fund Advisors bought 251,317 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $4.91M.
  • Portola Pharmaceuticals, Inc. made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1664 holding.
  • BlackRock Fund Advisors first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Portola Pharmaceuticals, Inc. position peaked at $97.9M in Q4 2015.
  • 150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.